Ajovy (fremanezumab, genetical recombination) is a subcutaneous injection, 225 mg/1.5 mL (YJ code: 1190407G1023), used for the preventive treatment of migraine in adults. Manufactured by Otsuka Pharmaceutical, it functions by blocking calcitonin gene-related peptide (CGRP) and can be administered once monthly or quarterly.
Ajovy subcutaneous injection 225 mg syringe
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).